All Stories

  1. Large-scale proteome profiling identifies circulating biomarkers for disease activity and organ involvement in ANCA-associated vasculitides

    Article • Frontiers in Immunology, June 2026, Frontiers

    Sophie Ohlsson

  2. Avacopan in a compassionate use programme for severe anti-neutrophil cytoplasmic antibody-associated vasculitis in Sweden

    Article • Scandinavian Journal of Rheumatology, May 2026, Taylor & Francis

    Sophie Ohlsson

  3. The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis

    Article • Frontiers in Immunology, June 2025, Frontiers

    Sophie Ohlsson

  4. In‐Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides Identifies Distinct Clinical Phenotypes

    Article • ACR Open Rheumatology, March 2025, Wiley

    Sophie Ohlsson

  5. Complement factors as biomarkers in ANCA-associated vasculitis in remission

    Article • Clinical & Experimental Immunology, January 2025, Oxford University Press (OUP)

    Sophie Ohlsson

  6. Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS)

    Article • American Journal of Respiratory and Critical Care Medicine, May 2024, American Thoracic Society

    Sophie Ohlsson

  7. The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)

    Article • Microbiology Spectrum, April 2024, ASM Journals

    Sophie Ohlsson

  8. The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

    Article • RMD Open, April 2024, BMJ

    Sophie Ohlsson

  9. Disease Activity and Tendency to Relapse in ANCA‐Associated Vasculitis Are Reflected in Neutrophil and Intermediate Monocyte Frequencies

    Article • Journal of Immunology Research, January 2024, Wiley

    Sophie Ohlsson

  10. The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)

    Article • Vaccine, May 2023, Elsevier

    Sophie Ohlsson

  11. Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis

    Article • Rheumatology, April 2023, Oxford University Press (OUP)

    Sophie Ohlsson

  12. Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study

    Article • Rheumatology, December 2022, Oxford University Press (OUP)

    Sophie Ohlsson, Prof. Maurizio Gallieni

  13. The Sound of Interconnectivity; The European Vasculitis Society 2022 Report

    Article • Kidney International Reports, August 2022, Elsevier

    Sophie Ohlsson

  14. Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA

    Article • Rheumatology, December 2021, Oxford University Press (OUP)

    Sophie Ohlsson

  15. Increased Frequencies of Switched Memory B Cells and Plasmablasts in Peripheral Blood from Patients with ANCA-Associated Vasculitis

    Article • Journal of Immunology Research, November 2020, Hindawi Publishing Corporation

    Sophie Ohlsson

  16. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2020, New England Journal of Medicine (NEJM/MMS)

    Sophie Ohlsson, Dr Stephen P McAdoo

  17. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

    Article • Nature Communications, November 2019, Springer Science + Business Media

    Sophie Ohlsson, Professor Pascale Salameh

  18. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation

    Article • PLOS One, June 2019, PLOS

    Sophie Ohlsson

  19. Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis

    Article • BMC Rheumatology, March 2019, Springer Science + Business Media

    Sophie Ohlsson

  20. Large expert-curated database for benchmarking document

    Article • Database, January 2019, Oxford University Press (OUP)

    Dr Daniel Prieto, Associate Professor James A.L. Brown, Professor Amanda G Thrift, Docent Kutty Selva Nandakumar, Professor Miguel Viveiros, MD Diego A. Valera-Cornejo, Dr Soroush Safaei, Dr Carmen San Martín, Piero Carninci, Dr Florian Rehfeldt, Dr Yoichi Watanabe, Kazuki Ide, Mr Alvin Wong, PD Dr. Adrian Meule, Dr Maurizio Petrelli, Dr Christine McGarrigle, Dr Tristan Reddan, Dr Nicola Roberts, Professor Stefan Lorkowski, Dr Cyrille Goarant, Dr Emma C Hobbs, Dr. Saurab Sharma, Ph.D., Dr Farid Rahimi, Prof. Iseult Lynch, Mirella Walker, Dr Luca Galluzzi, Sophie Ohlsson, Professor Tullio Florio, Dr Rabea A Gadelkareem, Dr Azubuike Christian Ukubuiwe, Prof Gajendra PS Raghava, Prof Jun Shen, Lubna Razak, ABHISHEKA BANSAL, Craig Billington, Dr Alejandro Lazo-Langner, Joan Albiol, MOURAD TAYEBI, Chuang Ma, Christine Toelzer , Dr. Kathrin Karsay, Professor Andrew M Beale, Professor Hugh James Byrne, Dr Ugo Marzocchi, Ana Nordberg, Martin Bartas, Natalia Echeverría, Dr Patricia M Graves, Dr Elvis A F Martis, Dr marco cascella, Dr. Giuseppe Lanza, Dr Michael Boah, Professor Bryan M. Wong, Luria Founou, Dr Marco J Haenssgen

  21. Genetically distinct clinical subsets, and associations with asthma and eosinophil abundance, within Eosinophilic Granulomatosis with Polyangiitis

    Article • December 2018, Cold Spring Harbor Laboratory Press

    Sophie Ohlsson

  22. Phenotypic Characterization of Circulating CD4+ T Cells in ANCA-Associated Vasculitis

    Article • Journal of Immunology Research, October 2018, Hindawi Publishing Corporation

    Sophie Ohlsson

  23. Monocyte Chemoattractant Protein-1 in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Biomarker Potential and Association with Polymorphisms in the MCP-1 and the CC Chemokine Receptor-2 Gene

    Article • Mediators of Inflammation, January 2018, Hindawi Publishing Corporation

    Sophie Ohlsson

  24. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

    Article • Kidney International, September 2017, Elsevier

    Dr Stephen P McAdoo, Sophie Ohlsson

  25. Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis

    Article • Journal of Allergy and Clinical Immunology, May 2017, Elsevier

    Sophie Ohlsson

  26. Neutrophils from ANCA-associated vasculitis shows an increased capacity to activate the complement system via the alternative pathway

    Article • Immunobiology, October 2016, Elsevier

    Sophie Ohlsson

  27. MO040ASSOCIATION OF A TNFSF13B (BAFF) REGULATORY REGION SINGLE NUCLEOTIDE POLYMORPHISMS WITH RESPONSE TO RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS

    Article • Nephrology Dialysis Transplantation, May 2016, Oxford University Press (OUP)

    Sophie Ohlsson

  28. TO037CLINICAL PREDICTORS OF RESPONSE TO RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS: A EUROPEAN COHORT

    Article • Nephrology Dialysis Transplantation, May 2016, Oxford University Press (OUP)

    Sophie Ohlsson

  29. Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis

    Article • April 2016, Springer Science + Business Media

    Sophie Ohlsson

  30. Autoantibodies Targeting a Collecting Duct–Specific Water Channel in Tubulointerstitial Nephritis

    Article • Journal of the American Society of Nephrology, March 2016, Wolters Kluwer Health

    Sophie Ohlsson

  31. In Reply to ‘IgG4-Restricted Anti–Glomerular Basement Membrane Autoantibodies Targeting Quaternary Epitopes of Native α345(IV) Collagen’

    Article • American Journal of Kidney Diseases, July 2014, Elsevier

    Sophie Ohlsson

  32. Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization

    Article • Clinical Immunology, May 2014, Elsevier

    Sophie Ohlsson

  33. Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti-neutrophil cytoplasmic antibodies

    Article • Clinical & Experimental Immunology, April 2014, Wiley

    Sophie Ohlsson

  34. Circulating Anti–Glomerular Basement Membrane Antibodies With Predominance of Subclass IgG4 and False-Negative Immunoassay Test Results in Anti–Glomerular Basement Membrane Disease

    Article • American Journal of Kidney Diseases, February 2014, Elsevier

    Sophie Ohlsson

  35. Urinary Concentration of Monocyte Chemoattractant Protein-1 in Idiopathic Glomerulonephritis: A Long-Term Follow-Up Study

    Article • PLOS One, January 2014, PLOS

    Sophie Ohlsson

  36. In vitro neutrophil activation by ANCA from patients with ANCA associated vasculitis; degranulation and oxidative burst

    Article • La Presse Médicale, April 2013, Elsevier

    Sophie Ohlsson

  37. Phagocytosis of apoptotic cells by macrophages in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis

    Article • Clinical & Experimental Immunology, September 2012, Oxford University Press (OUP)

    Sophie Ohlsson

  38. Genetically Distinct Subsets within ANCA-Associated Vasculitis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2012, New England Journal of Medicine (NEJM/MMS)

    Sophie Ohlsson

  39. Urinary Biomarkers in Glomerulonephritis

    Article • September 2011, IntechOpen

    Sophie Ohlsson

  40. Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP

    Article • Journal of Leukocyte Biology, September 2009, Oxford University Press (OUP)

    Sophie Ohlsson

  41. Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis

    Article • Mediators of Inflammation, January 2009, Hindawi Publishing Corporation

    Sophie Ohlsson

  42. Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis

    Article • Nephrology Dialysis Transplantation, January 2006, Oxford University Press (OUP)

    Sophie Ohlsson

  43. Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis

    Article • Clinical & Experimental Immunology, May 2005, Oxford University Press (OUP)

    Sophie Ohlsson

  44. Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?

    Article • Mediators of Inflammation, January 2004, Hindawi Publishing Corporation

    Sophie Ohlsson

  45. Point Mutations of Single Amino Acids Abolish Ability of α3 NC1 Domain to Elicit Experimental Autoimmune Glomerulonephritis in Rats

    Article • Journal of Biological Chemistry, November 2003, Elsevier

    Sophie Ohlsson

  46. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission

    Article • Clinical & Experimental Immunology, February 2003, Oxford University Press (OUP)

    Sophie Ohlsson

  47. Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis

    Article • Clinical & Experimental Immunology, January 2003, Oxford University Press (OUP)

    Sophie Ohlsson

  48. Novel distribution of the secretory leucocyte proteinase inhibitor in kidney

    Article • Mediators of Inflammation, January 2001, Hindawi Publishing Corporation

    Sophie Ohlsson

  49. Distribution of the Secretory Leucocyte Proteinase Inhibitor in Human Articular Cartilage

    Article • Biological Chemistry, January 1997, De Gruyter

    Sophie Ohlsson